Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010-2017.

MLA

Poizeau, Florence, et al. “Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010-2017.” The Journal of Investigative Dermatology, vol. 141, no. 4, Apr. 2021, p. 830. EBSCOhost, https://doi.org/10.1016/j.jid.2020.07.038.

APA

Poizeau, F., Kerbrat, S., Happe, A., Rault, C., Drezen, E., Balusson, F., Tuppin, P., Guillot, B., Thuret, A., Boussemart, L., Dinulescu, M., Pracht, M., Lesimple, T., Droitcourt, C., Oger, E., & Dupuy, A. (2021). Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010-2017. The Journal of Investigative Dermatology, 141(4), 830. https://doi.org/10.1016/j.jid.2020.07.038

Chicago

Poizeau, Florence, Sandrine Kerbrat, André Happe, Caroline Rault, Erwan Drezen, Frédéric Balusson, Philippe Tuppin, et al. 2021. “Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010-2017.” The Journal of Investigative Dermatology 141 (4): 830. doi:10.1016/j.jid.2020.07.038.